Stay updated on KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial

Sign up to get notified when there's something new on the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision history updated to include Revision: v3.3.2 and remove Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-28T13:09:52.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision: v3.3.1 is now displayed, replacing the previous v3.2.0.
    Difference
    0.2%
    Check dated 2025-11-21T13:19:18.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The funding-status warning banner about government funding lapses was removed. The page continues to present the study details and locations.
    Difference
    0.2%
    Check dated 2025-11-14T08:12:28.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Core study details appear unchanged. The visible updates seem to be routine metadata like the study location list and the update timestamp.
    Difference
    0.2%
    Check dated 2025-10-31T01:33:11.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Introducing a government-funded status notice and a version upgrade to v3.2.0, replacing v3.0.2.
    Difference
    3%
    Check dated 2025-10-02T08:27:11.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Core content removing MedlinePlus drug safety topics and related MeSH terms; overall narrowing of drug-safety coverage.
    Difference
    0.7%
    Check dated 2025-09-25T02:46:25.000Z thumbnail image

Stay in the know with updates to KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page.